Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

How CDK comes unglued

June 18, 2020

Shanghai Pharmaceuticals Holding patents MAPK11 and 14 inhibitors

June 16, 2020

Genmab presents positive topline data from ANDROMEDA study of daratumumab

May 29, 2020

Ottawa Hospital Research Institute, United Therapeutics disclose MSCs overexpressing AOAH

May 29, 2020

Sorrento receives FDA clearance to initiate a phase I study of STI-6129 in amyloidosis

May 27, 2020

New TYK2 inhibitors disclosed by Bristol-Myers Squibb

May 26, 2020

S166 phosphorylation is essential for cell death and inflammation in RIPK1-dependent diseases

May 5, 2020

Oral drug can wake up telomerase

April 29, 2020

Rejuvenating inflammation's end

April 15, 2020

The dose makes the poison -- timing, too

April 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...